investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

Investing in the Future: Fernwood Investment Management's Q3 2022 vs. Q4 2022 Holdings Comparison

Ava Hoppe | 26 April, 2023

Investing has always been a crucial aspect of building wealth, and in today's fast-paced world, it has become all the more important. The stock market has been on a rollercoaster ride, and investors have been looking for ways to navigate through the ever-evolving landscape. One such investor is Fernwood Investment Management, LLC.

Fernwood is an investment management company that focuses on equity investments in the United States. The company is known for its long-term perspective and has a strong reputation for providing clients with exceptional service. Recently, in Q3 2022, Fernwood made some changes to its holdings, and we will be comparing them to Q4 2022 holdings.

In Q3 2022, Fernwood's top holdings included Texas Pacific Land Corporation, iShares S&P 500 Index, and Apple Inc. These holdings were followed by Pliant Therapeutics, Vanguard Mega Cap Growth ETF, and iShares Dow Jones US Consumer Goods. In comparison, Q4 2022 saw some minor changes in holdings, with Pliant Therapeutics taking the top spot, followed by iShares S&P 500 Index and Texas Pacific Land Corporation.

One of the significant changes in Q4 2022 was Fernwood's investment in CISO, or Cerberus Cyber Sentinel Corp. The company's stock saw a significant rise in value, with Fernwood's holdings soaring from 20,000 shares to 410,000 shares. This aggressive move toward cybersecurity reflects Fernwood's strategy of investing in companies that are fundamental to the future.

Another noteworthy change was the shift away from Amazon.com Inc. Amazon's stock saw a considerable fall in value, with Fernwood's holdings decreasing from 43,703 shares to 44,578 shares. The decrease in value is in line with the overall trend in the market, with tech stocks taking a hit in recent times.

Fernwood's investments also show their focus on companies in the healthcare sector. Eli Lilly and Co. saw a significant increase in value, with a rise from $4,597,000 to $5,207,000. Similarly, Johnson & Johnson saw an increase in value, with Fernwood's holdings rising from 20,270 shares to 20,225 shares.

In conclusion, Fernwood's Q3 2022 vs. Q4 2022 holdings comparison shows a focus on investing in the future. The cybersecurity sector in particular shows immense potential, and Fernwood's investment in CISO reflects their bullish approach to this growing market. Similarly, their increased investments in healthcare companies are indicative of a long-term investment strategy that puts emphasis on companies that provide stability and growth potential.

Fernwood's portfolio changes also reflect the current state of the market, with a shift away from tech companies and a focus on sectors that have shown resilience in the face of ongoing market volatility. As always, the key to successful investing is to stay focused on long-term goals, and Fernwood's investment strategy of staying true to this approach has proved to be a winning formula.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.